BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gowing G, Svendsen S, Svendsen CN. Ex vivo gene therapy for the treatment of neurological disorders. Prog Brain Res 2017;230:99-132. [PMID: 28552237 DOI: 10.1016/bs.pbr.2016.11.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Padmakumar S, D'Souza A, Parayath NN, Bleier BS, Amiji MM. Nucleic acid therapies for CNS diseases: Pathophysiology, targets, barriers, and delivery strategies. J Control Release 2022;352:121-45. [PMID: 36252748 DOI: 10.1016/j.jconrel.2022.10.018] [Reference Citation Analysis]
2 Pandey S, Jirásko M, Lochman J, Chvátal A, Chottova Dvorakova M, Kučera R. iPSCs in Neurodegenerative Disorders: A Unique Platform for Clinical Research and Personalized Medicine. JPM 2022;12:1485. [DOI: 10.3390/jpm12091485] [Reference Citation Analysis]
3 Abdelghany S, Alshaer W, Al Thaher Y, Al Fawares M, Al-bakri AG, Zuriekat S, Mansour RS. Ciprofloxacin-loaded dissolving polymeric microneedles as a potential therapeutic for the treatment of S. aureus skin infections. Beilstein J Nanotechnol 2022;13:517-27. [DOI: 10.3762/bjnano.13.43] [Reference Citation Analysis]
4 Freed WJ. Parkinson’s Disease. Motivation and Desire 2022. [DOI: 10.1007/978-3-031-10477-0_17] [Reference Citation Analysis]
5 Sagen J, Hernandez M, Eeswara A, Gross S, Jergova S. Cell transplantation for reducing neuropathic pain after SCI. Spinal Cord Injury Pain 2022. [DOI: 10.1016/b978-0-12-818662-6.00020-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gilmutdinova IR, Kudryashova IS, Kostromina EY, Yakovlev MY, Yafarova IK, Gilmutdinov RG, Kaverina IA, Ershov AV, Isaev AN, Moskalev AA. Modern Approaches to Diagnostics and Correction of Aging Biomarkers. Bulletin of Rehabilitation Medicine 2021;20:96-102. [DOI: 10.38025/2078-1962-2021-20-6-96-102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Parambi DGT, Alharbi KS, Kumar R, Harilal S, Batiha GE, Cruz-Martins N, Magdy O, Musa A, Panda DS, Mathew B. Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases. Mol Neurobiol 2021. [PMID: 34655056 DOI: 10.1007/s12035-021-02555-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
8 Liu Y, Deng J, Liu Y, Li W, Nie X. FGF, Mechanism of Action, Role in Parkinson's Disease, and Therapeutics. Front Pharmacol 2021;12:675725. [PMID: 34234672 DOI: 10.3389/fphar.2021.675725] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Kang HP, Ihn H, Robertson DM, Chen X, Sugiyama O, Tang A, Hollis R, Skorka T, Longjohn D, Oakes D, Shah R, Kohn D, Jakus AE, Lieberman JR. Regional gene therapy for bone healing using a 3D printed scaffold in a rat femoral defect model. J Biomed Mater Res A 2021. [PMID: 34018305 DOI: 10.1002/jbm.a.37217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Jarrin S, Hakami A, Newland B, Dowd E. Growth Factor Therapy for Parkinson's Disease: Alternative Delivery Systems. J Parkinsons Dis 2021. [PMID: 33896851 DOI: 10.3233/JPD-212662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Pimentel-Vera LN, Poletto E, Gonzalez EA, de Oliveira Poswar F, Giugliani R, Baldo G. Genome editing in lysosomal disorders. Prog Mol Biol Transl Sci 2021;182:289-325. [PMID: 34175045 DOI: 10.1016/bs.pmbts.2021.02.001] [Reference Citation Analysis]
12 Andreana I, Repellin M, Carton F, Kryza D, Briançon S, Chazaud B, Mounier R, Arpicco S, Malatesta M, Stella B, Lollo G. Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies. Pharmaceutics 2021;13:278. [PMID: 33669654 DOI: 10.3390/pharmaceutics13020278] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
13 Proshkina EN, Solovev IA, Shaposhnikov MV, Moskalev AA. Key Molecular Mechanisms of Aging, Biomarkers, and Potential Interventions. Mol Biol 2020;54:777-811. [DOI: 10.1134/s0026893320060096] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
14 Duvergé A, Negroni M. Pseudotyping Lentiviral Vectors: When the Clothes Make the Virus. Viruses 2020;12:E1311. [PMID: 33207797 DOI: 10.3390/v12111311] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
15 Gyertyán I. How can preclinical cognitive research further neuropsychiatric drug discovery? Chances and challenges. Expert Opinion on Drug Discovery 2020;15:659-70. [DOI: 10.1080/17460441.2020.1739645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Al Qtaish N, Gallego I, Villate-Beitia I, Sainz-Ramos M, López-Méndez TB, Grijalvo S, Eritja R, Soto-Sánchez C, Martínez-Navarrete G, Fernández E, Puras G, Pedraz JL. Niosome-Based Approach for In Situ Gene Delivery to Retina and Brain Cortex as Immune-Privileged Tissues. Pharmaceutics 2020;12:E198. [PMID: 32106545 DOI: 10.3390/pharmaceutics12030198] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
17 Siju EN, Rajalakshmi GR. Neuropharmacology: Looking Forward to the Future. Principles of Neurochemistry 2020. [DOI: 10.1007/978-981-15-5167-3_10] [Reference Citation Analysis]
18 Shahlaei M, Asl SM, Saeidifar M. Nanotechnology in gene delivery for neural regenerative medicine. Neural Regenerative Nanomedicine 2020. [DOI: 10.1016/b978-0-12-820223-4.00005-x] [Reference Citation Analysis]
19 Hwang K, Jung K, Kim IS, Kim M, Han J, Lim J, Shin JE, Jang JH, Park KI. Glial Cell Line-derived Neurotrophic Factor-overexpressing Human Neural Stem/Progenitor Cells Enhance Therapeutic Efficiency in Rat with Traumatic Spinal Cord Injury. Exp Neurobiol 2019;28:679-96. [PMID: 31902156 DOI: 10.5607/en.2019.28.6.679] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
20 Rosenberg JB, Chen A, Kaminsky SM, Crystal RG, Sondhi D. Advances in the Treatment of Neuronal Ceroid Lipofuscinosis. Expert Opin Orphan Drugs 2019;7:473-500. [PMID: 33365208 DOI: 10.1080/21678707.2019.1684258] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
21 Killian T, Buntz A, Herlet T, Seul H, Mundigl O, Längst G, Brinkmann U. Antibody-targeted chromatin enables effective intracellular delivery and functionality of CRISPR/Cas9 expression plasmids. Nucleic Acids Res 2019;47:e55. [PMID: 30809660 DOI: 10.1093/nar/gkz137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
22 Tolmachov OE. Shielding of non-target cells using RNA vectors conferring gene transfer resistance: A strategy to enhance targeting accuracy and reduce side-effects in therapeutic gene delivery. Med Hypotheses 2019;132:109328. [PMID: 31421422 DOI: 10.1016/j.mehy.2019.109328] [Reference Citation Analysis]
23 Do HV, Khanna R, Gotschall R. Challenges in treating Pompe disease: an industry perspective. Ann Transl Med 2019;7:291. [PMID: 31392203 DOI: 10.21037/atm.2019.04.15] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
24 Jiang C, Chen J, Li Z, Wang Z, Zhang W, Liu J. Recent advances in the development of polyethylenimine-based gene vectors for safe and efficient gene delivery. Expert Opinion on Drug Delivery 2019;16:363-76. [DOI: 10.1080/17425247.2019.1604681] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
25 Tabrizi SJ, Ghosh R, Leavitt BR. Huntingtin Lowering Strategies for Disease Modification in Huntington’s Disease. Neuron 2019;101:801-19. [DOI: 10.1016/j.neuron.2019.01.039] [Cited by in Crossref: 122] [Cited by in F6Publishing: 126] [Article Influence: 30.5] [Reference Citation Analysis]
26 Tolmachov OE. Swarm Intelligence in Cell Entry Exclusion Phenomena in Viruses and Plasmids: How to Exploit Intelligent Gene Vector Self-Scattering in Therapeutic Gene Delivery. Global Virology III: Virology in the 21st Century 2019. [DOI: 10.1007/978-3-030-29022-1_10] [Reference Citation Analysis]
27 Serra J, Alves CPA, Brito L, Monteiro GA, Cabral JMS, Prazeres DMF, da Silva CL. Engineering of Human Mesenchymal Stem/Stromal Cells with Vascular Endothelial Growth Factor-Encoding Minicircles for Angiogenic Ex Vivo Gene Therapy. Hum Gene Ther 2019;30:316-29. [PMID: 30200778 DOI: 10.1089/hum.2018.154] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
28 Abati E, Bresolin N, Comi GP, Corti S. Preconditioning and Cellular Engineering to Increase the Survival of Transplanted Neural Stem Cells for Motor Neuron Disease Therapy. Mol Neurobiol. 2019;56:3356-3367. [PMID: 30120734 DOI: 10.1007/s12035-018-1305-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
29 Akhtar AA, Gowing G, Kobritz N, Savinoff SE, Garcia L, Saxon D, Cho N, Kim G, Tom CM, Park H, Lawless G, Shelley BC, Mattis VB, Breunig JJ, Svendsen CN. Inducible Expression of GDNF in Transplanted iPSC-Derived Neural Progenitor Cells. Stem Cell Reports 2018;10:1696-704. [PMID: 29706501 DOI: 10.1016/j.stemcr.2018.03.024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
30 Thomsen GM, Avalos P, Ma AA, Alkaslasi M, Cho N, Wyss L, Vit JP, Godoy M, Suezaki P, Shelest O, Bankiewicz KS, Svendsen CN. Transplantation of Neural Progenitor Cells Expressing Glial Cell Line-Derived Neurotrophic Factor into the Motor Cortex as a Strategy to Treat Amyotrophic Lateral Sclerosis. Stem Cells. 2018;36:1122-1131. [PMID: 29656478 DOI: 10.1002/stem.2825] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 11.4] [Reference Citation Analysis]
31 Lu X, Gu R, Hu W, Sun Z, Wang G, Wang L, Xu Y. Upregulation of heme oxygenase-1 protected against brain damage induced by transient cerebral ischemia-reperfusion injury in rats. Exp Ther Med 2018;15:4629-36. [PMID: 29805479 DOI: 10.3892/etm.2018.6049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]